Samara Capital likely to buy Novartis brands Industry-The Economic Times — June 30, 2017 comments off “Samara Capital is bullish on this segment and 7-8 brands which are part of the anti-infective portfolio will be acquired as part of the deal,” said one of the two sources cited above.
